Drug interactions
Glyburide-metformin + Lemborexant
Severity: Minor
Glyburide-metformin and Lemborexant: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Weak CYP3A4 inhibitors can raise lemborexant exposure, increasing next-day somnolence and impaired psychomotor performance. Glyburide is only a weak CYP3A4 inhibitor, so the effect is likely small.
What this interaction means in plain words
Glyburide-metformin and Lemborexant have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Glyburide-metformin belongs to Endocrine; Lemborexant belongs to Central Nervous System.
Why it happens
Weak inhibition of CYP3A4-mediated lemborexant metabolism.
What to do
Watch for daytime sedation and impaired alertness. Consider the lower lemborexant dose if excess sedation occurs.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Glyburide-metformin and Lemborexant, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Glyburide-metformin
Other interactions of Lemborexant
Frequently asked questions
Can I take Glyburide-metformin with Lemborexant?
MediHelp rates the interaction as minor. Glyburide-metformin and Lemborexant have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Weak CYP3A4 inhibitors can raise lemborexant exposure, increasing next-day somnolence and impaired psychomotor performance. Glyburide is only a weak CYP3A4 inhibitor, so the effect is likely small.
How serious is the interaction between Glyburide-metformin and Lemborexant?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Watch for daytime sedation and impaired alertness. Consider the lower lemborexant dose if excess sedation occurs.
What other medicines interact with Glyburide-metformin?
MediHelp also lists interactions of Glyburide-metformin with, for example, Bosentan, Cholic acid, Clarithromycin. The full list is on the Glyburide-metformin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.